# Tipifarnib in Treating Patients With Recurrent Bladder Cancer

> **NCT00047216** · PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto**

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** tipifarnib

## Key facts

- **NCT ID:** NCT00047216
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2006-03
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2015-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00047216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00047216, "Tipifarnib in Treating Patients With Recurrent Bladder Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00047216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*